Park Ha Biological Technology Co. Ltd
(PHH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 456,000 | 622,000 | 790,000 | 639,000 | 1,200,000 |
| Cost of Goods | 277,000 | 361,000 | 341,000 | 358,000 | 448,000 |
| Gross Profit | 179,000 | 261,000 | 449,000 | 281,000 | 752,000 |
| Operating Expenses | 296,000 | 361,000 | 441,000 | 346,000 | 332,000 |
| Operating Income | -117,000 | -100,000 | 8,000 | -65,000 | 420,000 |
| Other Income | -156,000 | -204,000 | -221,000 | -219,000 | -280,000 |
| Pre-tax Income | -273,000 | -304,000 | -213,000 | -284,000 | 140,000 |
| Income Tax | -79,000 | -111,000 | -82,000 | -99,000 | 42,000 |
| Net Income Continuous | -194,000 | -193,000 | -131,000 | -185,000 | 98,000 |
| Net Income Discontinuous | N/A | N/A | N/A | 272,000 | 66,000 |
| Minority Interests | 23,000 | 9,000 | 14,000 | 6,000 | 29,000 |
| Net Income | $-217,000 | $-202,000 | $-145,000 | $81,000 | $135,000 |
| EPS Basic Total Ops | -4.62 | -3.77 | -2.62 | 1.47 | 2.36 |
| EPS Basic Continuous Ops | -4.14 | -3.60 | -2.37 | -3.47 | 1.21 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 4.94 | 1.15 |
| EPS Diluted Total Ops | -4.62 | -3.77 | -2.62 | 1.47 | 2.06 |
| EPS Diluted Continuous Ops | -4.14 | -3.60 | -2.37 | -3.47 | 1.05 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 4.94 | 1.01 |
| EPS Diluted Before Non-Recurring Items | -4.47 | -2.74 | -2.74 | -2.55 | -0.29 |
| EBITDA(a) | $-103,000 | $-84,000 | $26,000 | $559,000 | $1,664,000 |